| Drug Name | Vyndamax (Tafamidis) |
|---|---|
| Drug Class | |
| Risk minimization type |
Healthcare provider guide
|
| Specialty (Theraputic area) |
Neurology
|
| Risk |
1. Avoidance of Pregnancy 2. THAOS - Transthyretin Amyloidosis Outcomes Survey 3. Clinical criteria for the diagnosis of ATTR-CM |
| Health care provider guide |
|